It is therefore conceivable that cardiomyocytes challenged with ischemia or other such metabolic stressors undergo alterations in cellular homeostatic and ion-handling mechanisms compared to healthy neonatal cells that are necessary for SGLT2i to inhibit CaMKII activity. Here, CAMK2G is linked to ischemia.